Rheumatoid arthritis

Are We on the Same Page? A Cross‐Sectional Study of Patient–Clinician Goal Concordance in Rheumatoid Arthritis

Arthritis Care Res (Hoboken)Published Cross-sectional study

Authors' conclusion

One in 5 patient-clinician dyads had discordant treatment goals. Goal concordance was associated with higher medication adherence.

Study context

Population
Adult patients with rheumatoid arthritis (RA) seen at least once in the prior 12 months at 1 of 2 rheumatology clinics, and their clinicians
Participants
204 patient-clinician dyads
Exposure
Goal-concordant vs goal-discordant patient–clinician dyads
Outcome
Patient–clinician goal concordance (patient's number 1 goal among clinician's top 3)
Methodological details2 rheumatology clinics, multivariable logistic regression
  • 2 rheumatology clinics
  • Multivariable logistic regression

Main finding

As reported in the abstract

Goal discordance

Discordant

20%

Observational data: associations, not effects.

Further findings

OutcomeaOR (95% CI)
Higher medication adherence2.76 (1.01–7.56)

Goals selected by both patient and clinician

"Have less pain", % of dyads
81%
"Have fewer problems doing daily activities", % of dyads
63%
Otherwise, clinicians prioritized avoiding side effects; patients ranked improved sleep, fatigue and mood

Disease duration

Longer disease duration associated with discordance (median 13.3 years among discordant vs 7 years, IQR 4-14)
P = 0.039

Depressive symptoms

Higher depressive symptoms associated with concordance (8.1% vs 24%)
P = 0.04

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Are We on the Same Page? A Cross‐Sectional Study of Patient–Clinician Goal Concordance in Rheumatoid Arthritis. Arthritis Care Res (Hoboken). Published 16 November 2022. doi:10.1002/acr.24794

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.